WindhoverV2.0
Home
Home		 Register
Register		 Login
Log In		 Schedule
Schedule		 Information
Info		 Attending Companies
Attendees		 Contact
Contact		 Help
Help
October 26-28, 2011InterContinental Mark HopkinsSan Francisco, CA

 

New Sessions Announced!

FDA, IOM and 510(k): Now What??
Joni Foy, Acting Deputy Director for Science and Regulatory at FDA’s Device Center, and other industry experts will discuss the Institute of Medicine’s controversial 510(k) report and other hot-button issues in the device indus­try, including pre-market review times and the future of user fees.


Business Challenges Facing Digital Health Ventures
Wireless and mobile health technologies are attracting the attention of traditional medical device firms, multi-sector technology giants, telecom companies and software start-ups. This interactive panel will explore the challenges facing various wireless health ventures, such as how to secure funding for R&D; which mobile health apps and devices face FDA regulation; and how to monetize wireless health by targeting clinicians, payers or consumers. Speakers will also address the importance of seeking partners across the broad spectrum of wireless health industry stakeholders.


Making the Pitch: What Do Dealmakers Want? (2 Parts)
In this interactive session, business development executives share their insights and perspectives based on actual company presentations, offering insights on what they like to see from smaller venture-backed companies.


Special Featured Panel Discussion for Medical Device Innovators
Angels, Grants and Venture Debt: Alternative Financing Strategies for those Seeking Funding in Today’s Difficult Marketplace.


VC Meet & Greet: Network with Top VCs and Business Development Executives
If you are a VC and/or Business Development Executive, this is a must attend event. This session, through facilitated meetings, brings VCs and business development executives together to better understand each others’ needs.



Who sends their teams to IN3 conferences? Here is just a small sample:

Abbott Laboratories Inc.
Alcon Laboratories, Inc.
Alloy Ventures
Baxter Healthcare Corp.
Baird Venture Partners
Becton Dickinson & Co.
Boston Scientific Corp.

C.R. Bard, Inc.
Covidien
Edwards Lifesciences
Ethicon Endo-Surgery, Inc.
HLM Venture Partners
Hospira, Inc.
Kimberly Clark Corp.

Medtronic, Inc.
New Leaf Venture Partners
Smith & Nephew, Inc.
St. Jude Medical
Stryker Corp.
SV Life Sciences
Versant Ventures

View Entire Company Listing
IN3 Summit 2011 is a must-attend event if you are…
  • • A medtech innovator interested in what top-tier venture capitalists and corporate acquirers want most in innovative technologies, therapeutic areas, products, and geographic markets. Hear partnering opportunities, case studies, how to maximize visibility in front of large company investors, and the role of M&A.
  • • A business development or financial community leader interested in investment, partnering, or acquisition opportunities with cutting-edge medtech innovators.
  • • A service provider or industry affiliate who is seeking to meet and support innovators and market leaders with their business needs.

In between presentation blocks, benefit from dedicated, 30-minute, break-out sessions for coffee socials, one-on-one private meetings, use of Windhover’s special partnering software, or network throughout the duration of the event.

 

IN3 Summit Testimonials

"The IN3 Medical Device Summit gave me a chance to meet one-on-one with potential corporate partners as well as several other high-quality investors, which to me represents exceptional value," said John Kraczkowsky, President and CEO of KCBioMedix®."
"The IN3 investor conferences deliver a first-class congress at which investors can productively identify advanced medical technologies at various stages of their development," said Jeani Delagardelle, a Managing Partner and leader of the medical device practice at New Leaf Venture Partners, a leading healthcare technology investor with more than $1 billion in funds under management."
"We are a repeat sponsor of Elsevier investor conferences," added Ann Gaddy, Managing Director, Life Science Angels. "The superior quality of the presenting companies makes IN3 the perfect venue in which to discover potentially blockbuster medical technology. It’s also a superbly managed gathering of buyers and sellers of medical technology."

Over 1,500 emerging medical technology company presenters and more than 8,000 attendees have participated at IN3 events over the past ten years. We are very proud to say that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at IN3 events. Click Here for success stories and testimonials from our past presenters and attendees.

About Partnering

    Why Use Windhover Conferences Partnering Software?

  • • Identify attendees to choose potential partners.
  • • Search database of partnering/investing opportunities (including deal history and related articles).
  • • Communicate and pre-schedule as many meetings as you wish with fellow attendees.
  • • Showcase your company's innovative technology and investment/partnering interests.

More Info >>

 

Contact Us


For registration, questions, or further information, contact:


Kristy Kennedy

Kristy J. Kennedy
Sales Director, Medical Device
Phone: 1-480-985-9512
Email: k.kennedy@elsevier.com

Kayleen Kell

Kayleen Kell
Associate Account Manager
Phone: 1-949-797-7142
1-855-202-5939 toll-free in the USA
Email: k.kell@elsevier.com

Kamran Hassan

Kamran Hassan
Associate Account Manager
Phone: 1-571-291-9664
Email: k.hassan@elsevier.com

 

About Partnering

 

Important Deadlines
Save $200 before: 08/26/2011
Last Chance for Discounted Rooms (may sell out earlier) 10/11/2011
Partnering Opens (start scheduling meetings) 10/11/2011
Innovator Company Profile Due 10/14/2011

View Full Pricing Schedule

 

Follow Us:

2011 Featured Speakers Include:

Mike Carusi
General Partner
Advanced Technology Ventures (ATV)

Leslie Bottorff
General Partner
ONSET Ventures

Josh Makower, MD
Founder and CEO
ExploraMed Development

James Stutz
Principle
Essex Woodlands Health Ventures

Mark Wan
Partner
Three Arch Partners

Jan Garfinkle
Founder and Managing Director
Arboretum Ventures

Doug Fisher
Principal
InterWest Partners

Zack Scott
Vice President
Saints Capital

Kevin Wasserstein
Managing Director
Versant Ventures

Paul Grand
Managing Director
RCT BioVentures

View Complete Bios

 

Who Attends

  • • Presidents, Principals, CEOs, CTOs, COOs, CMOs
  • • Founders, Board Leaders, Chairpersons
  • • Venture Partners, Senior Investors, Private Equity, Angel Investors
  • • VPs/Directors of Strategic Planning, Business Development/Analysis, Marketing, New Technology, Acquisitions, R&D, Sales

From These Types of Companies

  • • Established, large device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
  • • VCs, private equity, investment firms/consultant, and investment banks.
  • • Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships.
  •  
  •  

Benefits of Attending

  • • Keynote panels with the medtech industry’s top investors:
    – What is motivating buyers today?
    – Where are the clinical/marketing opportunities?
    – Which technologies stand out?
    – Which companies would be a good investment/acquisition and why?
  • • Innovative early/mid and late-stage company presentations.
  • • Global networking opportunities with hundreds of potential VCs, top investors and corporate acquirers.
  • • Company presentations by key investors who share their criteria.
  • • Partnering software so you can schedule 1:1 meetings.

 

Medical Devices Today